AU2001253707A1 - Use of ursodeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy - Google Patents

Use of ursodeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy

Info

Publication number
AU2001253707A1
AU2001253707A1 AU2001253707A AU5370701A AU2001253707A1 AU 2001253707 A1 AU2001253707 A1 AU 2001253707A1 AU 2001253707 A AU2001253707 A AU 2001253707A AU 5370701 A AU5370701 A AU 5370701A AU 2001253707 A1 AU2001253707 A1 AU 2001253707A1
Authority
AU
Australia
Prior art keywords
potentiation
photodynamic therapy
ursodeoxycholic acid
phototoxic effect
phototoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253707A
Inventor
David Kessel
John J. Reiners
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Original Assignee
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne State University filed Critical Wayne State University
Publication of AU2001253707A1 publication Critical patent/AU2001253707A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001253707A 2000-05-04 2001-04-20 Use of ursodeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy Abandoned AU2001253707A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20189400P 2000-05-04 2000-05-04
US60201894 2000-05-04
PCT/US2001/012813 WO2001082860A2 (en) 2000-05-04 2001-04-20 Use of ursodeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy

Publications (1)

Publication Number Publication Date
AU2001253707A1 true AU2001253707A1 (en) 2001-11-12

Family

ID=22747714

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253707A Abandoned AU2001253707A1 (en) 2000-05-04 2001-04-20 Use of ursodeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy

Country Status (2)

Country Link
AU (1) AU2001253707A1 (en)
WO (1) WO2001082860A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105694851B (en) * 2016-03-08 2018-07-27 武汉大学 A kind of cancer target diagnosis and treatment fluorescence probe

Also Published As

Publication number Publication date
WO2001082860A2 (en) 2001-11-08
WO2001082860A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
EP1212327B8 (en) Pyrazolopyrimidines as therapeutic agents
AU2002362482A1 (en) Acne treatment using oleanolic acid
AU2003224654A1 (en) Photodynamic therapy for pre-melanomas
AU2001247615A1 (en) Intracorporeal medicaments for photodynamic treatment of disease
AU2001255524A1 (en) Compositions and methods for the therapy and diagnosis of acne vulgaris
AU2001252135A1 (en) Therapeutic agents
AU2002218742A1 (en) Application of photochemotherapy for the treatment of cardiac arrhythmias
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002324279A1 (en) Porphyrin derivatives for photodynamic therapy
AU2003272317A1 (en) Treatment of periodontal disease with photosensitizers
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU2003247005A1 (en) Therapy combination
AU2001260834A1 (en) The treatment of herpes
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU2001243515A1 (en) Combination drug therapy
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU3082401A (en) Therapy of psoriasis
AU2003224000A1 (en) Compounds useful as photodynamic therapeutic agents
AU2451500A (en) Therapeutic agents
AU2002218750A1 (en) Photoactivated drug therapy
AU2001273903A1 (en) Therapeutic agents
AU2001253707A1 (en) Use of ursodeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy
AU5973600A (en) Therapeutic agents